Event Details
Date: 15 June 2023 - 17 June 2023

Location name: London, UK

Location address: Hilton London Metropole, 225 Edgware Road, London, W2 1JU, UK



Preview

The World Congress on Thyroid Cancer (WCTC) meets in London next month for the first time since 2019. More than 800 thyroid professionals will participate in a robust programme that includes the latest surgical technologies, RAI dedifferentiation advances and TKI-targeted treatment and immunotherapy options. 

WCTC was first held in Toronto, Canada and is now established as the largest and most highly regarded international meeting dedicated to improving the care of patients with thyroid cancer. Clinically focused and multi-disciplinary, this meeting is unique in attracting surgeons, endocrinologists, medical oncologists, pathologists, and other professionals dedicated to the field of thyroid oncology. 

The pre-conference day on Wednesday 14 June includes ultrasound courses and global forums. 

The main conference begins on Thursday 15 June with a keynote from James Fagin followed by a panel discussing Genetics and Genomics of Thyroid Cancer. Further sessions include: 

  • Molecular Diagnostics and Prognostics 
  • Ablative Technologies in Thyroid Nodules and Cancer 
  • Focus Practice Designation in Adult Complex Thyroid and Parathyroid Surgery 
  • Ultrasound for Diagnosis and Treatment of Thyroid Disease 
  • Surgery for Thyroid Cancer 
  • Advances in New Technologies 
  • Post-Operative Management in Differentiated Thyroid Cancer 
  • Management of Differentiated Thyroid Cancer 
  • Low Risk Differentiated Thyroid Cancer 
  • Paediatric Thyroid Cancer 
  • Anaplastic and Poorly Differentiated Thyroid Cancer 
  • Medullary Thyroid Carcinoma 
  • Rare Tumours of the Thyroid Gland 
  • Preoperative Evaluation of Thyroid Carcinoma 
  • Advances in Cytology and Pathology of Thyroid Neoplasia 
  • Guideline Updates: Towards a Common Global Standard 
  • Diversity, Equity and Inclusion in Thyroid Cancer 

In addition, there are instructional courses, meet the professor sessions, and a record number of outstanding oral, video, and electronic abstracts to experience over three days. 

This is a rare opportunity to meet with the world’s leading experts in thyroid cancer. The previous in-person meetings attracted more than 1000 attendees, while the more recent virtual offerings in 2021 and 2022 attracted more than 1500 unique, real-time attendees, with thousands of additional viewers of the online content following the live meetings. 

Full programme 

Register now